2026 Q3 Portfolio Activity
In 2026 Q3, Prosight Management, LP maintained a portfolio of 45 distinct positions. The most significant new addition was PRIVIA HEALTH GROUP INC, now representing 4.01% of the total fund value. They heavily accumulated shares in ABIVAX SA, increasing the position by 250.9%. The fund also reduced its exposure to BOSTON SCIENTIFIC CORP by 56.7%.
Position History
hover any row below to update
Loading…
Total Positions
45
Quarter
2026 Q3
Top Holding
GLPG (11.5%)
Top 10 Concentration
70.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-45 of 45
Prosight Management, LP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GLPG
LAKEFRONT BIOTH...
|
Healthcare | 11.49% | 10.56% |
#1
Prev: #1
|
6.5 |
—
|
-44,944 | -2.2% |
P
S
|
1,998,400 | $59,252,560 | 2018 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
STTK
SHATTUCK LABS I...
|
Healthcare | 10.12% | 7.12% |
#2
3
Prev: #5
|
8.0 |
—
|
1,690,217 | 28.4% |
P
S
|
7,648,094 | $52,160,001 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 9.87% | 10.07% |
#3
1
Prev: #2
|
4.9 |
—
|
-861,281 | -22.6% |
P
S
|
2,943,200 | $50,858,496 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 9.22% | 9.74% |
#4
1
Prev: #3
|
4.7 |
—
|
-25,000 | -3.1% |
P
S
|
785,000 | $47,527,825 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 7.24% | 2.47% |
#5
9
Prev: #14
|
6.4 |
—
|
269,400 | 250.9% |
P
S
|
376,794 | $37,310,142 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
INSM
INSMED INC
|
Healthcare | 5.27% | 6.90% |
#6
Prev: #6
|
2.1 |
—
|
-137,521 | -36.6% |
P
S
|
238,088 | $27,175,364 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 4.66% | 9.34% |
#7
3
Prev: #4
|
1.9 |
—
|
-720,273 | -56.7% |
P
S
|
550,000 | $24,007,500 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IRTC
IRHYTHM HOLDING...
|
Healthcare | 4.43% | 3.39% |
#8
3
Prev: #11
|
4.3 |
—
|
35,480 | 21.4% |
P
S
|
200,980 | $22,843,387 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 4.32% | 3.56% |
#9
1
Prev: #10
|
4.2 |
—
|
155,611 | 39.5% |
P
S
|
550,000 | $22,286,000 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PRVA
PRIVIA HEALTH G...
|
Healthcare | 4.01% | — |
#10
Prev: #—
|
5.1 |
—
|
1,049,752 | — |
NEW
|
1,049,752 | $20,669,617 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 3.90% | 2.09% |
#11
5
Prev: #16
|
4.6 |
—
|
350,205 | 77.9% |
P
S
|
800,000 | $20,104,000 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 3.71% | 3.04% |
#12
1
Prev: #13
|
3.5 |
—
|
46,666 | 6.9% |
P
S
|
721,100 | $19,101,939 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 2.96% | 4.52% |
#13
5
Prev: #8
|
1.2 |
—
|
-387,418 | -32.3% |
P
S
|
812,582 | $15,276,542 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 2.65% | 3.82% |
#14
5
Prev: #9
|
1.1 |
—
|
-746,964 | -36.9% |
P
S
|
1,275,000 | $13,655,250 | 2018 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 2.21% | — |
#15
Prev: #—
|
4.4 |
—
|
550,700 | — |
NEW
|
550,700 | $11,382,969 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 2.06% | — |
#16
Prev: #—
|
4.3 |
—
|
36,400 | — |
NEW
|
36,400 | $10,600,772 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
HQY
HEALTHEQUITY IN...
|
Healthcare | 1.99% | — |
#17
Prev: #—
|
4.3 |
—
|
115,796 | — |
NEW
|
115,796 | $10,243,314 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 1.91% | — |
#18
Prev: #—
|
4.3 |
—
|
150,000 | — |
NEW
|
150,000 | $9,870,000 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 1.77% | 5.09% |
#19
12
Prev: #7
|
0.7 |
—
|
-61,080 | -62.3% |
P
S
|
37,000 | $9,129,380 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
HUM
HUMANA INC
|
Healthcare | 1.63% | — |
#20
Prev: #—
|
4.2 |
—
|
22,000 | — |
NEW
|
22,000 | $8,394,540 | 2019 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ENOV
ENOVIS CORPORAT...
|
Healthcare | 0.95% | — |
#21
Prev: #—
|
3.9 |
—
|
267,432 | — |
NEW
|
267,432 | $4,885,983 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
OKUR
ONKURE THERAPEU...
|
Healthcare | 0.70% | 0.77% |
#22
2
Prev: #24
|
2.8 |
—
|
346,578 | 35.4% |
P
S
|
1,325,570 | $3,612,178 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
QTRX
QUANTERIX CORP
|
Healthcare | 0.59% | — |
#23
Prev: #—
|
3.7 |
—
|
825,000 | — |
NEW
|
825,000 | $3,060,750 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
GENB
GENERATE BIOMED...
|
Healthcare | 0.42% | — |
#24
Prev: #—
|
3.7 |
—
|
144,756 | — |
NEW
|
144,756 | $2,174,235 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ANTX
AN2 THERAPEUTIC...
|
Healthcare | 0.36% | 0.40% |
#25
4
Prev: #29
|
0.1 |
—
|
-123,761 | -26.1% |
P
S
|
350,877 | $1,866,666 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PLRX
PLIANT THERAPEU...
|
Healthcare | 0.34% | 0.27% |
#26
4
Prev: #30
|
2.1 |
—
|
234,233 | 17.1% |
P
S
|
1,604,466 | $1,732,823 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RCKT
ROCKET PHARMACE...
|
Healthcare | 0.30% | 0.41% |
#27
1
Prev: #28
|
0.6 |
—
|
-104,976 | -15.0% |
P
S
|
595,024 | $1,564,913 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RNTX
REIN THERAPEUTI...
|
Healthcare | 0.26% | 0.20% |
#28
6
Prev: #34
|
3.1 |
—
|
560,197 | 50.9% |
P
S
|
1,660,197 | $1,334,798 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
COYA
COYA THERAPEUTI...
|
Healthcare | 0.22% | 0.17% |
#29
6
Prev: #35
|
2.6 |
—
|
59,600 | 35.1% |
P
S
|
229,600 | $1,150,296 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 0.22% | 1.05% |
#30
10
Prev: #20
|
0.1 |
—
|
-481,617 | -74.1% |
P
S
|
168,383 | $1,148,372 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IMRX
IMMUNEERING COR...
|
Healthcare | 0.12% | 0.03% |
#31
5
Prev: #36
|
3.0 |
—
|
113,139 | 306.9% |
P
S
|
150,000 | $614,250 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 0.09% | 1.44% |
#32
15
Prev: #17
|
0.0 |
—
|
-7,424,849 | -94.9% |
P
S
|
399,900 | $487,878 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ASGN
EVERFORTH INC
|
Technology | 0.00% | 0.21% |
Sold All 😨
(Was: #33) |
0.0 |
—
|
-67,500 | -100.0% |
CLOSED
|
— | $— | 2018 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
MGTX
MEIRAGTX HLDGS ...
|
Healthcare | 0.00% | 0.21% |
Sold All 😨
(Was: #32) |
0.0 |
—
|
-90,000 | -100.0% |
CLOSED
|
— | $— | 2018 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.00% | 0.24% |
Sold All 😨
(Was: #31) |
0.0 |
—
|
-39,731 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KIDS
ORTHOPEDIATRICS...
|
Healthcare | 0.00% | 0.52% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-157,500 | -100.0% |
CLOSED
|
— | $— | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PFE
PFIZER INC
|
Healthcare | 0.00% | 0.56% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-135,366 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
EBS
EMERGENT BIOSOL...
|
Healthcare | 0.00% | 0.66% |
Sold All 😨
(Was: #25) |
0.0 |
—
|
-459,952 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
OPCH
OPTION CARE HEA...
|
Healthcare | 0.00% | 0.98% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-270,716 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
WGS
GENEDX HOLDINGS...
|
Healthcare | 0.00% | 1.01% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-85,500 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PRCT
PROCEPT BIOROBO...
|
Healthcare | 0.00% | 1.04% |
Sold All 😨
(Was: #21) |
0.0 |
—
|
-268,269 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 0.00% | 1.16% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-17,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ICUI
ICU MED INC
|
Healthcare | 0.00% | 1.29% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-51,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 0.00% | 2.42% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-374,666 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
VEEV
VEEVA SYS INC
|
Healthcare | 0.00% | 3.25% |
Sold All 😨
(Was: #12) |
0.0 |
—
|
-106,200 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-45 of 45 holdings